Summary

In summary, the field of tumor marker generation is evolving rapidly, with a convergence of molecular biology and technology and understanding of clinical trial design and analysis. Several of the large cooperative trialists' groups have now established separate correlative/biologic committees that are charged with designing hypothesis-driven LOE I and II studies, based on results from pilot studies. The emergence of erbB-2 in breast cancer as a predictive factor, in a manner similar to ER, may serve as a model of directed studies that lead to determination of the relative strength of the marker and determination of whether it should be used clinically. One hopes that careful and thoughtful consideration of study design will considerably shorten the life cycle required to being a tumor marker from the laboratory to the clinic.

Acknowledgment. Supported in part by NIH grant CA64057 and by the Fashion Footwear Association of New York (FFANY)/QVC Presents/Shoes on Sale.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment